Recce Pharmaceuticals Ltd

ASX:RCE.AX

0.51 (AUD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q2
Omzet 02.3814.36503.08500.9970.640.051.07200.680.8620.4270.13900.040.1370.11400
Kosten van de omzet 0.1730.1930.1420.0750.0790.1080.2050.0910.10.10.0290.3660.2380.2140.7030.3680.1760.0570.02800.083
Brutowinst -0.1732.1884.223-0.0753.006-0.1080.7920.549-0.050.971-0.0290.3130.6230.212-0.564-0.368-0.1360.080.0860-0.083
Brutowinstmarge 00.9190.96700.97400.7940.858-1.0080.90600.4610.7230.498-4.0490-3.4080.5850.7550-3,961.667
Onderzoek- en ontwikkelingskosten 04.7233.0854.0823.8062.4181.683.8771.2590.7260.0930.3230.1780.1940.6420.3570.14200.05400
Algemene en administratieve kosten 01.0190.9250.9250.3070.3070.4140.4140.2080.20800000000000
Verkoop- en marketingkosten 08.3961.1188.2550.9944.6150.69610.4140.192.05200000000000
Verkoop-, algemene en administratieve kosten 12.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6820.8680.8550.7310.6740.7193.8840.3960.32200.087
Overige kosten 000000000000000000000
Bedrijfskosten 12.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6821.3421.2761.2441.14410.7434.0320.35100.102
Bedrijfsresultaat -12.444-9.608-8.07-9.255-9.12-5.03-4.446-10.918-3.047-2.361-1.711-1.029-0.601-1.031-1.677-1.368-4.212-0.433-0.2650-0.185
Bedrijfsresultaat ratio 0-4.034-1.8490-2.9560-4.458-17.059-60.932-2.2030-1.513-0.697-2.415-12.0410-105.378-3.158-2.3280-8,803.238
Totaal overige inkomsten en kosten netto -0.381-0.135-0.0960.0330.0320.0470.1990.0860.062-0.042-0.013-0.037-0.029-0.013-0.0160.0353.327-3.523-00-0
Inkomen voor belasting -12.825-9.743-8.166-9.223-9.088-4.984-4.247-10.832-2.985-2.404-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.2650-0.185
Inkomen voor belasting ratio 0-4.091-1.8710-2.9460-4.259-16.924-59.699-2.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.3290-8,811.333
Belastingkosten -2.625-2.281-4.3110-3.085-0-0.926-0.64-0-1.07200000000000
Nettowinst -10.2-7.462-3.855-9.223-6.003-4.984-3.321-10.192-2.985-1.332-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.2650-0.185
Nettowinstmarge 0-3.133-0.8830-1.9460-3.33-15.924-59.699-1.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.3290-8,811.333
WPA (Winst Per Aandeel) -0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.0060-0.009
Verwaterde WPA -0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.0060-0.009
EBITDA -12.27-9.414-7.929-9.18-9.041-4.922-4.241-10.828-2.946-2.261-1.682-1.002-0.573-1.006-1.663-1.357-4.201-0.427-0.260-0.18
EBITDA ratio 0-3.953-1.8160-2.9310-4.253-16.917-58.923-2.110-1.474-0.665-2.355-11.9370-105.121-3.114-2.2860-8,582.81